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Abstract We previously showed that the post-translational
cleavage of Kv subunit is essential for integrin-dependent signal-
ling and cell adhesion. Here, we report that blocking Kv subunit
cleavage by expression of K1-PDX, a convertase inhibitor,
modi¢ed the capacity of cells to change shape, via a remodelling
of the actin cytoskeleton upon cell attachment. These changes
are associated with cell scattering and with a dramatic increase
in cell migration to vitronectin. The Kv subunit cleavage is thus
essential for integrin function and has a considerable impact on
integrin-dependent events, especially those leading to cell migra-
tion.
$ 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Cell migration is essential for many important biological
events, including embryonic development, in£ammatory re-
sponses, wound healing and tumour metastasis. Motility re-
quires adhesive interactions of cells with the extracellular ma-
trix (ECM). These interactions are partly mediated by
integrins, a family of cell surface adhesion receptors [1,2].
Integrins are heterodimeric proteins produced by the non-co-
valent association of K and L subunits. Although 18 K and
eight L subunits have been described, only 24 di¡erent combi-
nations have been identi¢ed to date. In addition to their struc-
tural role as bridges between the ECM proteins and the actin
cytoskeleton, integrins also play a critical role in signal trans-
duction events (for a review see [3^5]).
Some integrin K chains undergo a post-translational cleav-
age in their extracellular domain by furin and PC5A [6,7].
These proprotein convertases belong to the subtilisin/kexin-
like family [8^10]. The potential clinical and pharmacological
role of the convertases fostered the development of several
inhibitors. The most promising protein-based speci¢c inhibi-
tor of proprotein convertases is the K1-antitrypsin Portland or
K1-PDX, a selective inhibitor of furin and, to a lesser extent,
of PC5B [11]. K1-PDX blocks the convertase-dependent pro-
cessing of various precursors, including integrins [12^15].
The role of proteolytic cleavage in integrin function is un-
clear. Arguably, this post-translational processing of K chain
is not required for ligand binding [13,16,17], but is essential
for K6L1 integrin activation by phorbol esters [18]. Moreover,
it has recently been reported that expression of the uncleaved
form of K6 integrin progressively increased relative to the
cleaved form during lens cell di¡erentiation, suggesting that
the uncleaved form of K6 integrin may have a unique role in
the embryonic lens [19].
In a previous report, we showed that inhibition of pro-Kv
cleavage by over-expression of K1-PDX impaired integrin
KvL5-mediated signal transduction leading to a reduced at-
tachment to vitronectin [13]. In the present study, we further
investigated the functional importance of the cleavage defect
for cell migration. We report that blocking the Kv subunit
cleavage by expression of the convertase inhibitor K1-PDX
had important repercussions on cytoskeleton remodelling,
leading to a dramatic increase in cell migration to vitronectin
when cells are stimulated by phorbol 12-myristate 13-acetate
(PMA). Thus, our results show that the cleavage of Kv sub-
unit is essential for the function of KvL5 integrin and has a
marked impact on integrin-dependent events, especially those
leading to cell migration.
2. Materials and methods
2.1. Reagents
Dulbecco’s modi¢ed Eagle’s medium (DMEM) was purchased from
Gibco (Cergy-Pontoise, France) and foetal bovine serum from Bio-
Whittaker (Fontenay-sous-Bois, France). Phosphate-bu¡ered saline
(PBS) was from Oxoid (Basingstoke, UK). G418, PMA and
TRITC-conjugated phalloidin were obtained from Sigma (St-Quentin
Fallavier, France). Laminin-1 and vitronectin were prepared accord-
ing to Timpl et al. [20] and Yatogho et al. [21], respectively. Mouse
monoclonal anti-vinculin antibody was from Santa Cruz Biotechnol-
ogy (Santa Cruz, CA, USA) and FITC-conjugated goat anti-mouse
antibodies were from Jackson (Baltimore, MD, USA).
2.2. Cell scattering
The control (empty vector; PDX0) and stably K1-PDX-transfected
(PDX39P) cells, originating from the HT29-D4 adenocarcinoma cell
line, were previously described [13]. Cells were grown in DMEM
supplemented with 10% foetal calf serum and 400 Wg/ml G418.
For cell scattering assay, cells were seeded at low density and al-
lowed to grow for 48 h to obtain small colonies. Medium was changed
to DMEM containing 0.1% bovine serum albumin (DMEM/BSA) and
cells were treated or not with 100 nM PMA for 4 h at 37‡C. Images
were taken under an inverted phase-contrast microscope.
2.3. Cell migration assays
Haptotaxis assays were performed using modi¢ed Boyden chambers
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as described elsewhere [22]. Brie£y, the undersurface of the membrane
was precoated with puri¢ed ECM proteins in PBS (10 Wg/ml vitronec-
tin or 30 Wg/ml laminin-1) for 1 h at 37‡C. The lower reservoir was
¢lled with the appropriate protein in DMEM/BSA and the membrane
was placed in the chamber. Cells obtained as a single cell suspension
in DMEM/BSA were treated or not with 100 nM PMA prior to being
added into the upper reservoir (100 000 cells/cm2). Following incuba-
tion for 5 h at 37‡C, non-migratory cells on the upper surface of the
membrane were wiped with a cotton swab and migrated cells on the
lower surface were stained with 0.125% Coomassie blue. Haptotaxis
was determined by counting cells in 10 microscopic ¢elds per well and
expressed as the average number of cells per microscopic ¢eld (mag-
ni¢cation: U320).
2.4. Cell spreading assay
Cells in single cell suspension in DMEM/BSA were seeded at low
density (10 000 cells/cm2) in substratum-coated well plates as already
described [22] and allowed to spread for 2 h at 37‡C. Measures of cell
spreading were performed on all cells from ¢ve randomly chosen mi-
croscopic ¢elds (50^70 cells per well). Image acquisition and cell area
quanti¢cation were performed using a Leica DM IRBE microscope
and the Metaview software (Princeton Instruments, Paris, France).
2.5. Fluorescence staining
Serum-starved cells in DMEM/BSA were plated onto vitronectin-
coated glass coverslips for 24 h with or without 100 nM PMA. Cells
were ¢xed in 3.7% paraformaldehyde, permeabilised with 70% meth-
anol and ice-cold acetone for 1 min, washed in PBS and blocked for
10 min with blocking bu¡er (PBS, 1% BSA). Primary antibodies were
diluted in blocking bu¡er and applied for 3 h in a moist chamber at
room temperature. After three washes with PBS, coverslips were in-
cubated for 45 min in blocking bu¡er containing FITC-conjugated
secondary antibodies. Actin was visualised by incubation with
TRITC-conjugated phalloidin. After washing, samples were perma-
nently mounted with Mowiol. Control staining was performed with-
out either primary or secondary antibodies. Images were captured and
Fig. 1. E¡ect of K1-PDX expression on the actin cytoskeleton organisation. PDX0 and PDX39P cells were allowed to adhere to a vitronectin-
coated surface (10 Wg/ml) for 24 h in the presence or absence of 100 nM PMA. After permeabilisation, cells were co-stained for vinculin with
an anti-vinculin antibody and FITC-coupled secondary antibody and for actin with TRITC-phalloidin. Scale bar: 10 Wm.
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analysed using a Leica DM IRBE microscope with cool Snap FX
camera and the Metaview software.
3. Results
3.1. K1-PDX expression alters the cell morphology
We previously reported that cells expressing high levels of
the convertase inhibitor K1-PDX showed a reduced attach-
ment to vitronectin [13]. Focal adhesions are specialised sites
of cell attachment to the ECM where integrin receptors link
the ECM to the actin cytoskeleton [1]. To determine whether
K1-PDX expression alters the cell distribution of focal adhe-
sions, serum-starved cells were allowed to spread on vitronec-
tin before double staining of actin ¢bres and vinculin, a com-
ponent of focal adhesion plaques.
As illustrated in Fig. 1, in mock-transfected cells (PDX0),
vinculin was concentrated in dots distributed all over the ven-
tral surface of cells and localised at the end of actin stress
¢bres. When PDX0 cells were induced to migrate by treat-
ment with the phorbol ester PMA, vinculin labelling was par-
tially redistributed in larger dots along the cell edge in lamel-
lipodia-like extensions. In PDX39P cells, expressing high
levels of K1-PDX inhibitor, vinculin immunostaining was al-
ready localised at the periphery of untreated cells and the
labelling distribution did not change with PMA stimulation.
We only noted an increase in the size of stained dots associ-
ated with lamellipodia-like extensions, consistent with an en-
hanced integrin clustering. The same observations were done
when labelling of focal adhesions was carried out using anti-
focal adhesion kinase (FAK) or anti-phosphotyrosine anti-
bodies (not shown). In addition, it is worth pointing out
that the actin cytoskeleton reorganisation in response to
PMA treatment was clearly di¡erent in the two cell lines
(Fig. 1). In the case of PDX0, we only observed a thickening
of stress ¢bres, while PDX39P displayed a complex network
of actin ¢laments.
Cell spreading re£ects the capacity of cells to change shape,
via a remodelling of the actin cytoskeleton, upon attachment
to ECM. We previously reported that PMA-induced migra-
tion of HT29-D4 cells is associated with an increased spread-
ing upon phorbol ester stimulation [22]. To determine whether
di¡erences in cytoskeleton organisation revealed by £uores-
cence staining were accompanied by a modi¢cation in cell
spreading, PDX cells treated or not with PMA were plated
on ECM protein substratum. After a 2-h incubation at 37‡C,
the cell area was determined by computer image analysis. In
the absence of treatment, no signi¢cant di¡erence could be
observed in cell area between both cells, whatever the adhe-
sion substratum (Fig. 2). However, upon PMA stimulation,
the cell surface of PDX39P cells plated on vitronectin was
signi¢cantly higher than that of control cells. In contrast,
both cells spread with the same e⁄ciency on laminin (Fig.
2) or type I collagen (not shown), two cleavage-independent
substrates [13].
3.2. K1-PDX expression increases cell motility
Cell migration results from polarised changes in cell shape
due to a continuous remodelling of the actin cytoskeleton.
The changes in the cytoskeleton organisation observed by
£uorescence staining in PMA-treated PDX39P cells could
thus re£ect an increased motility. To address this question,
we ¢rst examined cell scattering in cell monolayers incubated
for 4 h in the presence or absence of PMA. As shown in Fig.
3, in the absence of any treatment, both cell types formed
tight colonies of adjacent epithelioid cells (Fig. 3a,b). When
stimulated by PMA, PDX0 cells displayed enlarged intercel-
lular spaces (Fig. 3c), suggesting that they migrated as coher-
ent cell sheets (cohort-type migration), as already observed
with the parental cells HT29-D4 [23]. The front cells of mi-
grating cell sheets acquired a motile morphology with leading
edges. Interestingly, results were drastically di¡erent on
PDX39P cells, as PMA had a scattering-like activity.
PDX39P cells dispersed from the cell islands into single cells
or small clusters of cells with a marked motile morphology
(Fig. 3d).
Because cell scattering is often accompanied by increased
cell motility, we used haptotaxis assays towards attractive
proteins in modi¢ed Boyden chambers. Cell motility was
quanti¢ed by counting the number of cells that migrated to
the underside of membrane. As matrix proteins, we used vi-
tronectin, the sole ligand for integrin KvL5 whose cleavage is
important for its function, and laminin-1 as a cleavage-inde-
pendent substrate [13]. Cells were unable to spontaneously
Fig. 2. E¡ect of K1-PDX expression on cell spreading. Cells were
seeded on substratum-coated surface (10 Wg/ml vitronectin or 30 Wg/
ml laminin-1) in the presence or absence of 100 nM PMA. After 2 h
at 37‡C, cells were ¢xed with 2.5% glutaraldehyde and their area
was measured by computer image analysis. Results ( U S.D.) are
from a representative experiment of four performed in duplicate.
Fig. 3. E¡ect of K1-PDX expression on PMA-induced cell scatter-
ing. Adherent PDX0 (a,c) and PDX39P cells (b,d) were treated (c,d)
or not (a,b) with 100 nM PMA. Images were taken by phase-con-
trast microscope after 4 h of treatment. Scale bar: 50 Wm.
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migrate towards ECM proteins (Fig. 4). However, both ECM
proteins supported migration of cells upon PMA stimulation
(Fig. 4), as previously reported for parental HT29-D4 cells
[22]. Moreover, protein kinase C-dependent migration of
PDX39P cells towards vitronectin was three- to four-fold
higher than that observed with PDX0 or HT29-D4 cells. In
contrast, laminin-1 supported cell migration with the same
e⁄ciency for all cell types (Fig. 4).
4. Discussion
Integrins confer di¡erent cell adhesive properties, particu-
larly with respect to focal adhesion formation and motility.
Cell migration towards vitronectin is supported by integrin
KvL5, the sole receptor for this ECM protein in the cells
used in this study (see [22,24] and data not shown). We
have previously shown that this integrin is not cleaved in
K1-PDX-expressing PDX39P cells. This leads to alterations
in signal transduction pathways activated by integrin ligation,
resulting in a reduced attachment to vitronectin [13]. Here we
demonstrate that migration of PDX39P cells towards vitro-
nectin is markedly increased when compared to parental
HT29-D4 or control PDX0 cells.
How does reduced adhesion lead to an enhanced motility?
As cell migration requires the formation of new attachments
at the cell front and the break of attachments at the rear,
maximum cell speed is predicted to occur at an intermediate
ratio of cell^substratum adhesiveness to intracellular contrac-
tile force [25,26]. The rate of cell migration versus ECM pro-
tein concentration is thus a bell-shaped curve in the case of
HT29-D4 cells [22]. Therefore, any experimental manipulation
that changes the adhesive state of the cell can potentially
cause either an increase or a decrease in cell migration, de-
pending upon where one is starting on the bell-shaped curve.
In the case of PDX39P cells, the reduced attachment to vitro-
nectin due to the unprocessing of Kv integrin subunit results
in a dramatically increased cell migration.
While the exact mechanism by which the absence of KvL5
integrin cleavage leads to such a di¡erence in the migratory
behaviour is not understood, one can suspect that integrin-
dependent signalling pathways might be involved. Thus, we
have previously reported that activation of mitogen-activated
protein kinase (MAPK) by protein kinase C is a prerequisite
in the pathway leading to the integrin-dependent migration of
HT29-D4 cells [22,23]. Moreover, immunolabelling experi-
ments have showed that, upon inducing migration by PMA
treatment, active MAPK is concentrated in lamellipodia-like
extensions (data not shown). The enhanced MAPK activity in
PDX39P cells [13] could therefore explain the higher motility
to vitronectin observed with these cells.
Recent structural studies have revealed that integrin activa-
tion and signalling are, at the molecular level, one and the
same process that needs large conformational changes propa-
gated through the transmembrane domains of the integrin
subunits [27^29]. The cleavage site of Kv subunit is localised
in the ectodomain nearby the plasma membrane, a region
essential for the activity of L3 integrins [30]. It thus can be
hypothesised that the endoproteolytic cleavage of K subunit
may provide for the conformational £exibility required for
integrin activation.
FAK phosphorylation, induced by KvL5 integrin ligation,
appears to contribute to the stabilisation of cell adhesion [31].
The phosphorylation level of FAK and its associated phos-
phoprotein paxillin, in response to ligation of KvL5 integrin, is
very low in the case of PDX39P [13]. The absence of cleavage
of the KvL5 integrin could thus lead to the impairment of
signal transduction by FAK (or another molecule) upon cell
adhesion, which in turn might result in a reduced e⁄ciency of
PDX39P cells attachment to vitronectin.
Our results clearly show that expression of the convertase
inhibitor K1-PDX leads to a cytoskeleton remodelling and a
marked increase in cell migration towards vitronectin when
cells are stimulated by PMA. In support of these observations,
we have established that this enhanced in vitro motility is
associated with a highly invasive behaviour of cells upon in-
oculation into immunosuppressed newborn rats, and that the
number of metastases is dramatically reduced when inocula-
tion is performed in association with a function-blocking anti-
body against Kv integrin subunit (Nejjari et al., submitted).
Thus, the cleavage of Kv integrin subunit appears to play an
essential role in KvL5 integrin-dependent events, especially
those leading to cell migration.
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